| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Loteprednol |
| Brand | Lotemax 0.5% eye drops suspension |
| Indication | For treatment of post-operative inflammation following ocular surgery. |
| Assessment Process | |
| Rapid review commissioned | 15/11/2011 |
| Rapid review completed | 05/12/2011 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Not Recommended |